N-Acetyl-D-Mannosamine

[{"orgOrder":0,"company":"National Human Genome Research Institute","sponsor":"National Center for Advancing Translational Sciences | Therapeutics for Rare and Neglected Diseases","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"N-Acetyl-D-Mannosamine","moa":"Undisclosed","graph1":"Immunology","graph2":"Phase I","graph3":"National Human Genome Research Institute","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"National Human Genome Research Institute \/ National Center for Advancing Translational Sciences | Therapeutics for Rare and Neglected Diseases","highestDevelopmentStatusID":"6","companyTruncated":"National Human Genome Research Institute \/ National Center for Advancing Translational Sciences | Therapeutics for Rare and Neglected Diseases"},{"orgOrder":0,"company":"Leadiant Biosciences","sponsor":"Brigham and Women's Hospital | National Human Genome Research Institute | National Institute of Neurological Disorders and Stroke | National Institute of Arthritis and Musculoskeletal and Skin Diseases | NeuroNext","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"N-Acetyl-D-Mannosamine","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II","graph3":"Leadiant Biosciences","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Leadiant Biosciences \/ Brigham and Women's Hospital | National Human Genome Research Institute | National Institute of Neurological Disorders and Stroke | National Institute of Arthritis and Musculoskeletal and Skin Diseases | NeuroNext","highestDevelopmentStatusID":"8","companyTruncated":"Leadiant Biosciences \/ Brigham and Women's Hospital | National Human Genome Research Institute | National Institute of Neurological Disorders and Stroke | National Institute of Arthritis and Musculoskeletal and Skin Diseases | NeuroNext"}]